Clinical Trial Update: Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Vinorelbine and Oxaliplatin (Vinox) with or without Trastuzumab (Herceptin) in advanced breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Trastuzumab (trastuzumab)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Breast Neoplasms | Phase 2 | Status: TERMINATED